| Source: |
| Type: |
| UBE2L3 - Ubiquitin-Conjugating Enzyme E2 L3 Abbreviation: UBE2L3, UBCH7, UBCM4 Type: E2 ubiquitin-conjugating enzyme Function: UBE2L3 transfers activated ubiquitin from E1 enzymes to substrates in cooperation with specific E3 ubiquitin ligases. It regulates protein stability, cell-cycle progression, NF-κB signaling, DNA-damage responses, proliferation, and cellular homeostasis through substrate-specific ubiquitination. Cancer: ↑ Frequently increased and oncogenic in several cancer contexts. Elevated UBE2L3 can promote proliferation, cell-cycle progression, tumor growth, and survival through ubiquitination-dependent regulation of proteins including p27/CDKN1B and components of oncogenic signaling pathways. High UBE2L3 expression has been associated with advanced disease and poorer outcomes in non-small-cell lung cancer. Its effects can vary depending on the associated E3 ligase and substrate. |
| 7587- | I3C, | Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest |
| - | in-vitro, | Cerv, | HeLa |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1665 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid